https://www.pharmaceutical-technology.com/news/celgene-signs-9bn-acquisition-deal-juno-therapeutics/
Celgene has entered a definitive merger agreement to acquire US-based biopharmaceutical firm Juno Therapeutics for $87 per share, totalling approximately $9bn.
juno therapeuticspharmaceutical technologycelgenesignsacquisition
https://www.fool.com/investing/2017/03/04/bad-news-biotechs-whats-next-for-juno-and-ptc-ther.aspx
Can Juno and PTC Therapeutics pick up the pieces after major pipeline setbacks?
bad newsbiotechsnextjunoptc